FDA approves birch triterpenes gel as topical medication for epidermolysis bullosa
The US Food and Drug Administration (FDA) has approved the new birch triterpenes topical gel (Filsuvez) for treating 2 variants of epidermolysis bullosa (EB).Birch triterpenes topical gel is designed for partial thickness wounds in seen in individuals aged 6 months and older with a diagnosis of Junctional Epidermolysis Bullosa (JEB) and with Dystrophic Epidermolysis Bullosa […]